The local and systemic effects of immune function on fracture healing.
fracture healing
immune modulation
precision medicine
Journal
OTA international : the open access journal of orthopaedic trauma
ISSN: 2574-2167
Titre abrégé: OTA Int
Pays: United States
ID NLM: 101770383
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
received:
13
12
2023
revised:
28
12
2023
accepted:
04
01
2024
medline:
15
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
epublish
Résumé
The immune system plays an integral role in the regulation of cellular processes responsible for fracture healing. Local and systemic influences on fracture healing correlate in many ways with fracture-related outcomes, including soft tissue healing quality and fracture union rates. Impaired soft tissue healing, restricted perfusion of a fracture site, and infection also in turn affect the immune response to fracture injury. Modern techniques used to investigate the relationship between immune system function and fracture healing include precision medicine, using vast quantities of data to interpret broad patterns of inflammatory response. Early data from the PRECISE trial have demonstrated distinct patterns of inflammatory response in polytrauma patients, which thereby directly and indirectly regulate the fracture healing response. The clearly demonstrated linkage between immune function and fracture healing suggests that modulation of immune function has significant potential as a therapeutic target that can be used to enhance fracture healing.
Identifiants
pubmed: 38487403
doi: 10.1097/OI9.0000000000000328
pii: OTAI-D-23-00083
pmc: PMC10936162
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e328Informations de copyright
Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association.
Déclaration de conflit d'intérêts
No conflict of interest for all authors and no funding received. Authors of this study wish to acknowledge the Major Extremity Trauma Research Consortium (METRC) for its contribution to the PRECISE Trial results reported in this manuscript.